The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

A chocolate recall was recently upgraded to warn consumers of a potential to “cause serious adverse health consequences of death.” ...

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A 5-year-old boy from Royal Oak was killed in an explosion while receiving hyperbaric oxygen therapy at a healthcare facility ...

Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

New poll reveals Americans' mixed views on weight-loss drugs for obesity treatment, especially regarding teen use.

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health condition ti ...